HIV STI & Herpes Protection Using Silicone Vaginal Rings

Author: American Society for Microbiology
Published: 21st Sep 2015
Peer-Reviewed Publication: N/A
Additional References: HIV and Aids Publications

Summary: Researchers develop vaginal silicone ring that delivers molecules that act on both HIV and herpes virus.

Main Document

This research is presented at the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC/ICC).

"We succeeded in creating a ring that can deliver hydrophilic molecules such as tenofovir, active on HIV-1, and acyclovir, active on herpes virus, despite the fact that silicone is a hydrophobic compound," said Meriam Memmi, author of the study and PhD candidate at University Jean Monnet of Saint-Etienne, France. This was possible due to the addition of a hydrophilic compound to the silicone, which allowed the drugs to be released from their reservoirs.

Vaginal rings with multiple reservoirs present a promising way for preventing sexually transmitted infections (STIs) and notably HIV infection in young women with high risk of exposure. Some of the rings presented in this study were shown to release concentrations of drugs between 1.5 and 3.5 mg/day for acyclovir and 3 to 5 mg/day for tenofovir for as long as 50 days, which corresponds to doses capable of preventing viral sexual-transmitted infections such as HIV-1 infection, hepatitis B and genital herpes.

These preliminary results demonstrate the ability of silicone rings to continuously deliver hydrophilic antiviral drugs for a long period of time at a concentration that would be effective for neutralizing the viruses present in semen. The process is intended to be evaluated in clinical trials and to be industrialized with the goal of producing rings at high rate and low cost.

"The aim of our study was to develop a vaginal silicone ring that was nontoxic to the health of users but was capable of delivering multiple active antiviral molecules against various STIs including HIV for a long duration," said Memmi.

STIs of viral origin constitute a major public health concern, notably in women from low-income countries who were shown to be infected with HIV-1 early in their sexual live, with a gap of 7 to 10 years compared to men. "It is difficult for women in these countries to master the prevention of STIs since the use of condoms and circumcision is mainly under the control of men," said Memmi.

The work was performed at the University Jean Monnet of Saint-Etienne, France, in close collaboration between a team of virologists belonging to the GIMAP group under the supervision of Pr. Bruno Pozzetto and of chemists from the Polymer Materials Engineering Laboratory under the supervision of Pr. Christian Carrot, with the help of Mr. Blaise Figuereo, a silicone engineer who designed the apparatus used to create the reservoir rings.

The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

This research was presented as part of ASM's Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) being held from September 17-21, 2015 in San Diego, California.

Post to Twitter Add to Facebook

Latest HIV and Aids Publications
The above information is from our reference library of resources relating to HIV and Aids that includes:
	Parent Focused HIV Prevention Intervention Online toolkit helps parents improve communication with gay and bisexual sons about behaviors to help them stay healthy. Publish Date: 13th Nov 2022 - Updated: 5th Jan 2023
	FDA Approves Trogarzo (ibalizumab-uiyk) for Patients with Limited HIV Treatment Options U.S. FDA approves Trogarzo for adult patients with HIV who have tried multiple medications and whose HIV infections cannot be treated with other therapies - multidrug resistant HIV, or MDR HIV. Publish Date: 7th Mar 2018
	Undetectable/Untransmittable: Gay - Bisexual Men Skeptical But Attitudes On The Rise Hunter CHEST study sought to examine how accurate gay and bisexual men perceive this message to be by surveying more than 12,000 men across the United States. Publish Date: 16th Jan 2018
	Transgender Women Take Triple the Number of HIV Tests As Trans Men Study revealed HIV testing among transgender adults was higher in those who identified as female, were African-American or Hispanic, or had a history of incarceration. Publish Date: 1st Nov 2017